Repetitive high-dose ifosfamide, thiotepa and paclitaxel (ITP) with peripheral blood progenitor cell support; A novel outpatient regimen for metastatic and locally advanced breast cancer.

被引：0
|
作者：
Prince, HM [1 ]
Millward, MJ [1 ]
Rischin, DR [1 ]
Blakey, D [1 ]
Wolf, M [1 ]
Januscewicz, H [1 ]
Toner, G [1 ]
Richardson, G [1 ]
Sharkey, P [1 ]
Dale, B [1 ]
机构：
[1] PETER MACCALLUM CANC INST,BLOOD & MARROW TRANSPLANT SERV,MELBOURNE,VIC 3000,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4575 / 4575
页数：1
相关论文
共 50 条
  • [31] Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer
    L De Rosa
    M Lalle
    A Pandolfi
    L Pescador
    Bone Marrow Transplantation, 2001, 27 : 1031 - 1035
  • [32] CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer
    Papadopoulos, KP
    Ayello, J
    Reiss, RF
    Troxel, A
    Kaufman, E
    Vahdat, LT
    Antman, KH
    Hesdorffer, CS
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 1999, 8 (04): : 357 - 363
  • [33] Salvage treatment with epirubicin and/or paclitaxel in metastatic breast cancer patients relapsed after high-dose chemotherapy with peripheral blood progenitor cells
    Tartarone, A
    Sirotovà, Z
    Aieta, M
    Lelli, G
    TUMORI JOURNAL, 2001, 87 (03): : 134 - 137
  • [34] High-dose weekly paclitaxel in metastatic and locally advanced breast cancer: A Brown University Oncology Group Study
    Sikov, W
    Akerley, W
    Strenger, R
    Cummings, F
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 33 - 33
  • [35] High dose chemotherapy - Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer
    De Rosa, L
    Lalle, M
    Pandolfi, A
    Pescador, L
    BONE MARROW TRANSPLANTATION, 2001, 27 (10) : 1031 - 1035
  • [36] HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN THE OUTPATIENT SETTING
    MICHELSON, GC
    GRINBLATT, D
    BYRNEMALLOY, R
    ZIMMERMAN, T
    WILLIAMS, SF
    CLINICAL RESEARCH, 1994, 42 (03): : A378 - A378
  • [37] High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer
    Rodenhuis, S
    Huitema, ADR
    van Dam, FSAM
    de Vries, EGE
    Beijnen, JH
    CANCER JOURNAL, 2000, 6 : S125 - S130
  • [38] Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer
    Honkoop, AH
    vanderWall, E
    Feller, N
    Schuurhuis, GJ
    vanderVijgh, WJF
    Boven, E
    vanGroeningen, CJ
    Giaccone, G
    Hoekman, K
    Vermorken, JB
    Wagstaff, J
    Pinedo, HM
    ANNALS OF ONCOLOGY, 1997, 8 (10) : 957 - 962
  • [39] High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer
    Bessho, A
    Ueoka, H
    Kiura, K
    Tabata, M
    Sunami, K
    Katayama, Y
    Yamane, H
    Hiraki, A
    Harada, M
    ANTICANCER RESEARCH, 1999, 19 (1B) : 693 - 698
  • [40] Preliminary results of high-dose chemotherapy (HDCT) with peripheral blood stem cell (PBSC) support in patients with breast cancer.
    Zmatchinski, V
    Uss, A
    Milanovich, N
    Skrahin, A
    Dzuba, E
    Mitskevich, O
    Zavgorodniay, I
    Batan, Z
    Vinogradov, V
    BONE MARROW TRANSPLANTATION, 1999, 23 : S193 - S193
12345